Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Mrja Therapeutics Inc. currently has 1 pending office action in its patent portfolio. This action is being handled by 1 distinct examiner. This represents a singular point of prosecution for the company at the patent office.
PECKHAM, RICHARD GRANT is the busiest examiner for the company, managing 1 busiest examiner pending action. As there is only 1 pending action in total, this examiner is responsible for all current active office actions for Mrja Therapeutics Inc.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PECKHAM, RICHARD GRANT | 1 | 68.1% | +35.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18835167 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | PECKHAM, RICHARD GRANT | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18835167 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | PECKHAM, RICHARD GRANT | — | §112 | Non-Final OA | — | Pending | Aug 01, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial